Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Liabilities from Discontinued Operations (2024)

Historic Liabilities from Discontinued Operations for Roivant Sciences (ROIV) over the last 1 years, with Q3 2024 value amounting to $401.2 million.

  • Roivant Sciences' Liabilities from Discontinued Operations changed N/A to $401.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $401.2 million, marking a year-over-year change of. This contributed to the annual value of $433.9 million for FY2024, which is N/A changed from last year.
  • Roivant Sciences' Liabilities from Discontinued Operations amounted to $401.2 million in Q3 2024.
  • In the past 5 years, Roivant Sciences' Liabilities from Discontinued Operations ranged from a high of $433.9 million in Q1 2024 and a low of $401.2 million during Q3 2024